Paper225666
Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.
Gadek JE and 7 others. N Engl J Med, 1979. Cited by 221 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. Papers, record 225666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/225666
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung | Major topic |
| Microbial Collagenase | Major topic |
| Pulmonary Fibrosis | Major topic |
| Adult | |
| Aged | |
| Body Fluids | |
| Bronchi | |
| Bronchoscopy | |
| Collagen | |
| Female | |
| Fiber Optic Technology | |
| Humans | |
| Lymphocytes | |
| Male | |
| Middle Aged | |
| Neutrophils | |
| Peptide Hydrolases | |
| Pulmonary Alveoli | |
| Therapeutic Irrigation | |
| Time Factors |
Source PubMed
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36834561 | Immune Mechanisms of Pulmonary Fibrosis with Bleomycin. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834561 | PubMed |
| 35740444 | Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts? | Biomedicines | 2022 | https://conductscience.org/library/papers/35740444 | PubMed |
| 34643929 | Curcumin inhibition of bleomycin-induced changes in lung collagen synthesis, deposition and assembly. | Mol Biol Rep | 2021 | https://conductscience.org/library/papers/34643929 | PubMed |
| 27247426 | Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis. | Biosci Rep | 2016 | https://conductscience.org/library/papers/27247426 | PubMed |
| 24726499 | Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. | Am J Pathol | 2014 | https://conductscience.org/library/papers/24726499 | PubMed |
| 19129758 | Pulmonary fibrosis: pathogenesis, etiology and regulation. | Mucosal Immunol | 2009 | https://conductscience.org/library/papers/19129758 | PubMed |
| 18447576 | MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. | PLoS Med | 2008 | https://conductscience.org/library/papers/18447576 | PubMed |
| 17569781 | Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17569781 | PubMed |
| 16598647 | Matrix metalloproteinase-1 activation via plasmin generated on alveolar epithelial cell surfaces. | Lung | 2006 | https://conductscience.org/library/papers/16598647 | PubMed |
| 11132772 | Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha. | Mediators Inflamm | 2000 | https://conductscience.org/library/papers/11132772 | PubMed |
| 10958381 | Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity. | Mediators Inflamm | 2000 | https://conductscience.org/library/papers/10958381 | PubMed |
| 9614183 | Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-alpha and 12-lipoxygenase metabolites: a model of macrophage-induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury. | Mol Biol Cell | 1998 | https://conductscience.org/library/papers/9614183 | PubMed |
| 9077541 | Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9077541 | PubMed |
| 8426465 | Comparison between lung parenchyma and bronchoalveolar lavage collagenolytic activity. | Lung | 1993 | https://conductscience.org/library/papers/8426465 | PubMed |
| 8322246 | New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. | Thorax | 1993 | https://conductscience.org/library/papers/8322246 | PubMed |
| 8016800 | Matrix metalloproteases and lung disease. | Thorax | 1994 | https://conductscience.org/library/papers/8016800 | PubMed |
| 7535685 | Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms. | Environ Health Perspect | 1994 | https://conductscience.org/library/papers/7535685 | PubMed |
| 7326869 | Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7326869 | PubMed |
| 7251862 | Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7251862 | PubMed |
| 7054232 | Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7054232 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/225666
GET https://conductscience.org/api/papers/v1/225666/cited_by?page=2